Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-31

Clinical Trial Update: TabCAT Brain Health Assessment in Primary Care [NA]

View source ↗

Summary

An update on the TabCAT brain health assessment trial shows it is currently recruiting in primary care for mild cognitive impairment and dementia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, San Francisco | Conditions: Mild Cognitive Impairment, Dementia | NA | Status: RECRUITING